Stanley and Rosanne Crooke stay focused on anti-sense, stealing back patients from disease with N-of-1 tech
A little over a year after a Boston Children’s Hospital neurologist used anti-sense technology to create what may be the world’s first fully bespoke therapy, two of the oldest and biggest names in anti-sense have launched a charity to make those treatments possible to far more patients – and free of charge.
The husband-and-wife team of longtime Ionis CEO Stanley Crooke and longtime Ionis researcher Rosanne Crooke are launching the n-Lorem foundation. The couple will personally contribute $1.5 million to the project, with Ionis adding another $1.5 million and Biogen $1 million. Stanley Crooke stepped down from Ionis’ helm last year.
Unlock this article instantly by becoming a free subscriber.
You’ll get access to free articles each month, plus you can customize what newsletters get delivered to your inbox each week, including breaking news.
